Main Menu

RayzeBio, Inc.

(NASDAQ GM: RYZB)

Rigrodsky Law, P.A. is investigating RayzeBio, Inc. (“RayzeBio”) regarding possible breaches of fiduciary duties and other violations of law related to RayzeBio’s agreement to be acquired by Bristol-Myers Squibb Company. Under the terms of the agreement, RayzeBio shareholders will receive $62.50 per share in cash.

Join This Action

Alternatively, you may upload your transactions using the upload button below or email them to info@rl-legal.com.

Draw your signature below using your mouse* [Clear]

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

Date of signing: 06/18/2024


* Indicates a required field.

Back to Page